Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shawn X Yin

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Current Opinion in Drug Discovery & Development|October 24, 2008
Selecting and controlling API crystal form for pharmaceutical development--strategies and processesShawn X Yin, John A Grosso
Journal of Pharmaceutical Sciences|June 2, 2005
Bioavailability enhancement of a COX-2 inhibitor, BMS-347070, from a nanocrystalline dispersion prepared by spray-dryingShawn X Yin, Miriam Franchini, Jinling Chen, et al.
Science (New York, N.Y.)|July 7, 2018
Single-crystal x-ray diffraction structures of covalent organic frameworksTianqiong Ma, Eugene A Kapustin, Shawn X Yin, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Current Opinion in Drug Discovery & Development|October 24, 2008
Selecting and controlling API crystal form for pharmaceutical development--strategies and processesShawn X Yin, John A Grosso
Journal of Pharmaceutical Sciences|June 2, 2005
Bioavailability enhancement of a COX-2 inhibitor, BMS-347070, from a nanocrystalline dispersion prepared by spray-dryingShawn X Yin, Miriam Franchini, Jinling Chen, et al.
Science (New York, N.Y.)|July 7, 2018
Single-crystal x-ray diffraction structures of covalent organic frameworksTianqiong Ma, Eugene A Kapustin, Shawn X Yin, et al.
Pageof 1